Design of translactam HCMV protease inhi
โ
Alan D. Borthwick
๐
Article
๐
2005
๐
John Wiley and Sons
๐
English
โ 908 KB
## Abstract Human cytomegalovirus (HCMV) is an important pathogen for which there is a significant unmet medical need. New HCMV antivirals, active against novel molecular targets, are undoubtedly needed as the currently available drugs ganciclovir, cidofovir, and foscarnet, which are all viral DNA